|
C5ORF45 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.605400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.077800E-01 |
| Normal-vs-Stage2 |
9.889000E-01 |
| Normal-vs-Stage3 |
4.265600E-01 |
| Normal-vs-Stage4 |
1.704810E-01 |
| Stage1-vs-Stage2 |
5.909000E-01 |
| Stage1-vs-Stage3 |
9.627400E-01 |
| Stage1-vs-Stage4 |
3.506000E-01 |
| Stage2-vs-Stage3 |
5.995600E-01 |
| Stage2-vs-Stage4 |
3.026800E-01 |
| Stage3-vs-Stage4 |
4.698000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.948790E-01 |
| Normal-vs-AfricanAmerican |
4.859400E-01 |
| Normal-vs-Asian |
7.680000E-01 |
| Caucasian-vs-AfricanAmerican |
8.839800E-01 |
| Caucasian-vs-Asian |
2.677800E-01 |
| AfricanAmerican-vs-Asian |
4.338000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.401200E-01 |
| Normal-vs-Female |
1.493590E-01 |
| Male-vs-Female |
2.351800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.953000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.404800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.233200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.173200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.975600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.399600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.741000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.596000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.000600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.686200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.20550000000053E-05 |
| Classical-VS-Follicular |
1.006030E-01 |
| Classical-VS-Other |
8.328100E-02 |
| Classical-VS-Normal |
2.404400E-01 |
| Tall-VS-Follicular |
4.67609999998952E-06 |
| Tall-VS-Other |
4.276300E-02 |
| Tall-VS-Normal |
1.21460000002127E-06 |
| Follicular-VS-Other |
3.568200E-01 |
| Follicular-VS-Normal |
4.540000E-01 |
| Other-VS-Normal |
3.262800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.363400E-01 |
| Normal-vs-N1 |
7.129800E-01 |
| N0-vs-N1 |
6.796400E-01 |
|
|
